Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status
OPEN Clinical colorectal cancer | 4 Nov 2017
S Siena, F Rivera, J Taieb, M Peeters, H Prenen, R Koukakis, G Demonty and CH Köhne
Köhne prognostic score is used to classify patients with metastatic colorectal cancer (mCRC) as high, intermediate, or low risk. Using data from 2 phase III trials, we analyzed survival in patients categorized according to Köhne prognostic category and virus-induced rapidly accelerated fibrosarcoma murine sarcoma viral oncogene homolog B (BRAF) mutation.
* Data courtesy of Altmetric.com